Zobrazeno 1 - 10
of 239
pro vyhledávání: '"Maddalena Napolitano"'
Autor:
Silvia Ferrucci, Maddalena Napolitano, Francesca Barei, Luca Valtellini, Angelo V. Marzano, Cataldo Patruno, Emanuela Martina, Anna Campanati
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 731-734 (2024)
Externí odkaz:
https://doaj.org/article/843525a4e52249cf9c7891143217bde6
Autor:
Paolo Amerio, Silvia Mariel Ferrucci, Marco Galluzzo, Maddalena Napolitano, Alessandra Narcisi, Anna Levi, Sara Di Fino, Chiara Palladino, Cataldo Patruno, Mariateresa Rossi
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 6, Pp 1443-1455 (2024)
Abstract Atopic dermatitis (AD) is a highly heterogeneous chronic inflammatory skin disorder that is frequently associated with a plethora of comorbidities. AD is, therefore, considered a systemic disease impacted by a considerable burden and leading
Externí odkaz:
https://doaj.org/article/dca1283cbe5b447288e6cb7dd29a8cc6
Autor:
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Anna G. Burroni, Andrea Chiricozzi, Paolo Dapavo, Silvia M. Ferrucci, Massimo Gola, Maddalena Napolitano, Michela Ortoncelli, Maria T. Rossi, Claudio Sciarrone, Antonio Costanzo, Alessandra Narcisi
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 4, Pp 919-932 (2024)
Abstract Introduction Several systemic therapies have been approved for the treatment of severe AD. In particular, Janus kinase inhibitors (JAKi), including abrocitinib, baricitinib, and upadacitinib, recently received approval for the treatment of p
Externí odkaz:
https://doaj.org/article/7023be759f84421298febcd280592b42
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractBackground: Injection site reaction (ISR) is a local phenomenon defined as a constellation of symptoms, including swelling, erythema, pruritus, and pain around the site of injection.Objective: ISR is reported as a frequent adverse event after
Externí odkaz:
https://doaj.org/article/347baf7508444a9d89b8c01af9393dec
Autor:
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, Valeria Boccaletti, Cristiana Colonna, Riccardo Cavalli, Iria Neri, Michela Ortoncelli, Donatella Schena, Luca Stingeni, Katharina Hansel, Vincenzo Piccolo, Veronica Di Brizzi, Concetta Potenza, Ersilia Tolino, Luca Bianchi, Sara Manti, Rocco De Pasquale, Vito Di Lernia, Lucia Caminiti, Elena Galli, Paola Coppo, Andrea Chiricozzi, Clara De Simone, Cristina Guerriero, Fabrizio Giuseppe Amoruso, Eugenio Provenzano, Salvatore Leonardi, Amelia Licari, Gian Luigi Marseglia, Antonino Palermo, Sabrina Di Pillo, Daniele Russo, Viviana Moschese, Vincenzo Patella, Tiziana Peduto, Caterina Ferreli, Paola Zangari, Federica Veronese, Samantha Federica Berti, Michaela Gruber, Elena Pezzolo, Stefania Termine, Rosanna Satta, Federica Dragoni, Maria Esposito, Maria Concetta Fargnoli, Paolo Chiodini, Ylenia Vallone, Francesca di Vico, Vincenzo Picone, Maddalena Napolitano
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background: Dupilumab has been shown to be a safe and effective drug for the treatment of atopic dermatitis (AD) in children from 6 months to 11 years in randomized clinical trials. Aim: The aim of this real-life study was to determine the effectiven
Externí odkaz:
https://doaj.org/article/fb3f28510b7a41c6a5913518338704e4
Autor:
Vincenzo Picone, MD, Maddalena Napolitano, MD, Ginevra Torta, MD, Gabriella Fabbrocini, MD, PhD, Cataldo Patruno, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 36, Iss , Pp 51-53 (2023)
Externí odkaz:
https://doaj.org/article/58c55af9a7f444dca39b2a9d65fc0426
Autor:
Cataldo Patruno, Luca Potestio, Massimiliano Scalvenzi, Teresa Battista, Flavia Raia, Vincenzo Picone, Gabriella Fabbrocini, Maddalena Napolitano
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 7, Pp 3028-3033 (2022)
Background Special populations (SPs) involve people who require additional consideration in clinical research. Effectiveness of treatment or occurrence of side effects may be different in SPs with respect to not-SPs. Objectives To retrospectively com
Externí odkaz:
https://doaj.org/article/4186d690bfd44fd0b1fb245663aa33b6
Autor:
Elena Pezzolo, Michela Ortoncelli, Silvia Mariel Ferrucci, Mario Bruno Guanti, Donatella Schena, Maddalena Napolitano, Mariateresa Rossi, Caterina Foti, Domenico D’Amico, Giuseppe Fabrizio Amoruso, Pietro Morrone, Simone Ribero, Francesca Barei, Matteo Biagi, Enrico Pascucci, Cataldo Patruno, Piergiacomo Calzavara Pinton, Paolo Romita, Luigi Gargiulo, Alessandra Narcisi, Luigi Naldi
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 2, p 553 (2024)
Background: Limited real-world data are available on upadacitinib drug survival in patients with atopic dermatitis (AD). Objectives: To investigate upadacitinib drug survival, and the reasons and predictors of drug discontinuation in AD patients. Met
Externí odkaz:
https://doaj.org/article/705cf9067ad248119e87e80db886fe52
Autor:
Maddalena Napolitano, Maria Mariano, Antonio Cristaudo, Stefano Dastoli, Adriana Di Guida, Mario De Lucia, Gianluca Guerrasio, Steven Paul Nisticò, Maria Passante, Flavia Pigliacelli, Gabriella Fabbrocini, Cataldo Patruno
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 5, Pp 2670-2673 (2022)
Purpose: This study provides a comparative survival analysis between the only two drugs approved in Italy for the treatment of moderate-to-severe AD, cyclospoorin, and dupilumab. Materials and methods: A multicenter, retrospective study, was performe
Externí odkaz:
https://doaj.org/article/f198c9626ba1460faaa92574b0536190
Autor:
Maddalena Napolitano, Francesca di Vico, Angelo Ruggiero, Gabriella Fabbrocini, Cataldo Patruno
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Recent evidence suggests that interleukin (IL)-13 is a crucial cytokine involved in the pathogenesis of atopic dermatitis (AD). It is a central driver of type-2 T-helper inflammation and is overexpressed in lesional skin of AD patients. Upon release
Externí odkaz:
https://doaj.org/article/e8063f5fe672436d90c7c05472682312